Kimia Therapeutics Funding: $55M Raised, Series A (2023)

Kimia Therapeutics is based in San Francisco, CA. It has raised $55M in total funding. Latest round: Series A.

Kimia Therapeutics funding overview

Kimia Therapeutics is based in San Francisco, CA. Kimia Therapeutics has raised $55M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2023. The round record for Kimia Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include The Column Group, Dimension, Horizons Ventures. 3 distinct backers are named across the disclosed rounds.

Kimia Therapeutics at a glance

Total raised
$55M
Latest round
Series A
Latest round date
December 2023
Headquarters
San Francisco, CA
Notable investors
The Column Group, Dimension, Horizons Ventures

Frequently asked about Kimia Therapeutics funding

How much has Kimia Therapeutics raised?
Kimia Therapeutics has raised $55M in total disclosed funding across the rounds on record.
Who has invested in Kimia Therapeutics?
The Column Group, Dimension, Horizons Ventures are named among the investors backing Kimia Therapeutics.
What was the latest Kimia Therapeutics funding round?
The most recent disclosed round is a Series A, announced in December 2023.
Where is Kimia Therapeutics based?
Kimia Therapeutics is based in San Francisco, CA.
When did Kimia Therapeutics last raise?
The last disclosed Kimia Therapeutics round closed in December 2023 at Series A.

Every Kimia Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in San Francisco at a similar stage.

Companies related to Kimia Therapeutics (36)

Browse related funding lists (7)

Company funding database · Investor directory · Founder database · Mega-rounds 2026